Crackdown on FDCs continues, latest ban to affect Rs 824 cr market: Study

72 pharmaceutical companies have brands that fall under banned FDCs, says one expert

The government’s ban on 14 fixed dose combination (FDC) drugs in "larger public interest" will affect around Rs 824 crore of the domestic pharmaceuticals market, said a research firm citing data.

Abbott, Mankind and Dr Reddy’s Laboratories are companies which make products that come under the banned FDCs, according to Pharmarack AWACS.

A FDC combines two or more active ingredients into a single drug formulation in a fixed dosage ratio. The government announced the ban last week upon the recommendation of an expert committee which said the FDCs had no "therapeutic justification". “Hence in the larger public interest, it is